STOCK TITAN

Azenta Inc Stock Price, News & Analysis

AZTA Nasdaq

Welcome to our dedicated page for Azenta news (Ticker: AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.

Azenta Inc (Nasdaq: AZTA) is a global leader in life sciences solutions, providing essential tools for drug development, clinical research, and genomic discovery. This page aggregates official press releases and verified news about the company’s advancements in cold-chain sample management, automated storage systems, and multiomics services.

Investors and researchers will find timely updates on Azenta’s operational milestones, including earnings reports, strategic partnerships, product innovations, and industry recognition. The curated content addresses key areas such as sample integrity technologies, genomic data accuracy, and global service expansions.

Key updates include developments from Azenta’s core segments: Life Sciences Products (automated storage solutions, lab consumables) and Life Sciences Services (genomic sequencing, multiomics analytics). Content is organized to help stakeholders track progress in critical research areas like precision medicine and biotherapeutic development.

Bookmark this page for streamlined access to Azenta’s latest announcements, or check regularly for insights into how the company continues to shape the future of life sciences infrastructure and biomedical innovation.

Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) reported financial results for Q2 fiscal 2024 with revenue of $159 million, up 7% YoY. Positive free cash flow for the fourth consecutive quarter. Strong organic revenue growth in Sample Management Solutions and B Medical Systems. Operating loss of $147 million, with operating margin at (92.3%). Non-GAAP diluted EPS improved to $0.05. Cash balance of $975 million. Share repurchase program ongoing. Lowered revenue guidance for FY2024 but raised earnings guidance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.89%
Tags
-
Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings on May 8, 2024, after market close. The Company will hold a conference call and webcast to discuss financial results the same day at 4:30 p.m. Eastern Time. Analysts, investors, and media can access the live webcast on the Azenta website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
conferences

FAQ

What is the current stock price of Azenta (AZTA)?

The current stock price of Azenta (AZTA) is $30.2 as of October 31, 2025.

What is the market cap of Azenta (AZTA)?

The market cap of Azenta (AZTA) is approximately 1.4B.
Azenta Inc

Nasdaq:AZTA

AZTA Rankings

AZTA Stock Data

1.37B
44.99M
1.8%
116.63%
7.89%
Medical Instruments & Supplies
Special Industry Machinery, Nec
Link
United States
BURLINGTON